DVADaVita

Health care · Health Services · NYSE

Unless otherwise indicated in this report "DaVita", "the Company" "we", "us", "our" and other similar terms refer to DaVita Inc. and its consolidated subsidiaries. 10-K, Item 1

Headquarters: Denver, CO
CEO: Javier Rodriguez
Next results: around Feb 1, 2027

Compare with peers → Embed

RevenueFY2016–25 $13.6B+6.5% Highest in 10 years 10-K FY2025 · XBRL Net incomeFY2016–25 $746.8M−20.2% FY2024: $936.3M 10-K FY2025 · XBRL Free cash flowFY2016–25 $1.3B−10.6% FY2024: $1.5B 10-K FY2025 · XBRL Operating marginFY2016–25 15.0%−1.3 pts 19.0% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 11, 2026 against Feb 13, 2025

Area	What changed	Source
Risk factors	29 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Inventory growing faster than revenue	Inventory +19.4% vs revenue +6.5% (+12.9 pts)	10-K · XBRL
Accounting checks	10 other checks clear, 1 worth a look	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	2 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 11, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-13. Quoted as filed.

Risks Related to Competition, Business Strategy Growth, Information Systems and New Technologies
10-K, Item 1A

All 29 new paragraphs →

Accounting checks

latest 10-K

10 of 11 clear 1 worth a look. Checks, not verdicts.

!
Inventory growing faster than revenueInventory +19.4% vs revenue +6.5% (+12.9 pts)
✓
Receivables +12.5% vs revenue +6.5% (+6.0 pts)
✓
Cash from operations $1.9B vs net income $746.8M (FY ending 2025-12-31)
✓
Same auditor in both 10-Ks: KPMG LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: U.S. dialysis patient service revenue recognition; F-2; Evaluation of legal proceedings and regulatory matters
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Oct 29, 20268-K Quarterly results 8-K item 2.02
Oct 29, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on DVA in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DVA/export.csv") into a cell.